These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1158 related articles for article (PubMed ID: 30980070)

  • 1. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
    Cho H; Abe S; Nonaka S; Suzuki H; Yoshinaga S; Okuma K; Yamamoto S; Daiko H; Kato K; Sekine S; Boku N; Saito Y
    Dis Esophagus; 2024 Apr; 37(5):. PubMed ID: 38266034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.
    Minashi K; Nihei K; Mizusawa J; Takizawa K; Yano T; Ezoe Y; Tsuchida T; Ono H; Iizuka T; Hanaoka N; Oda I; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Doyama H; Oyama T; Nebiki H; Amagai K; Kubota Y; Nishimura K; Kobayashi N; Suzuki T; Hirasawa K; Takeuchi T; Fukuda H; Muto M
    Gastroenterology; 2019 Aug; 157(2):382-390.e3. PubMed ID: 31014996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma.
    Koterazawa Y; Nakamura T; Oshikiri T; Kanaji S; Tanaka S; Ishida T; Yamashita K; Matsuda T; Morita Y; Suzuki S; Kakeji Y
    Surg Today; 2018 Aug; 48(8):783-789. PubMed ID: 29532261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study.
    Tasaki Y; Yamazaki T; Miyazaki S; Takeda T; Nakatake M; Nakamura D; Takahira A; Honda K; Egawa A; Yamaguchi N; Nakao K; Toya R
    BMC Gastroenterol; 2024 Jul; 24(1):232. PubMed ID: 39044174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
    Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
    Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
    Tsou YK; Lee CH; Le PH; Chen BH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study.
    Zhang T; Wang H; Jin T; Wu Z; Li X; Zhang Q
    J Cancer Res Clin Oncol; 2024 May; 150(5):248. PubMed ID: 38724804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcome of Additional Esophagectomy After Endoscopic Treatment for Superficial Esophageal Cancer.
    Miyata H; Sugimura K; Kanemura T; Takeoka T; Yamamoto M; Shinno N; Hara H; Omori T; Yamamoto S; Ishihara R; Wada H; Takahashi H; Nishimura J; Matsuda C; Yasui M; Yano M
    Ann Surg Oncol; 2021 Nov; 28(12):7230-7239. PubMed ID: 33959832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Nagasawa S; Watanabe S; Seri S; Asato A; Shiozaki A; Fujiwara H; Konishi H; Dohi O; Ishikawa T; Elsaleh H; Yamada K
    Radiat Oncol; 2022 Nov; 17(1):191. PubMed ID: 36401267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion.
    Ikeda A; Hoshi N; Yoshizaki T; Fujishima Y; Ishida T; Morita Y; Ejima Y; Toyonaga T; Kakechi Y; Yokosaki H; Azuma T
    Intern Med; 2015; 54(22):2803-13. PubMed ID: 26567992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
    Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
    Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review.
    Kam TY; Kountouri M; Roth A; Frossard JL; Huber O; Mönig S; Zilli T
    Crit Rev Oncol Hematol; 2018 Apr; 124():61-65. PubMed ID: 29548487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.